Xilio Therapeutics, Inc. Depreciation
Xilio Therapeutics, Inc. (XLO) reported Depreciation of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- Xilio Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $300.00K, a 25.00% decline year-over-year.
- Xilio Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $300.00K, a 40.00% decline year-over-year.
- Xilio Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $300.00K, a 25.00% decline year-over-year.
- Xilio Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $300.00K, a 25.00% decline year-over-year.
- Xilio Therapeutics, Inc. depreciation for fiscal 2025 was $1.50M, a 6.25% decline from fiscal 2024.
- Xilio Therapeutics, Inc. depreciation for fiscal 2024 was $1.60M, a 11.11% decline from fiscal 2023.
- Xilio Therapeutics, Inc. depreciation for fiscal 2023 was $1.80M, a 5.88% increase from fiscal 2022.
- Xilio Therapeutics, Inc. depreciation for fiscal 2022 was $1.70M, a 21.43% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-12 | $700.00K 10-Q · filed 2026-08-12 | $900.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.20M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-12 | $600.00K derived: sum of 2 quarters · filed 2026-05-12 | $900.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.30M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $600.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.00M derived: sum of 3 quarters · filed 2026-08-12 | $1.50M 10-K · filed 2026-03-23 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-13 | $700.00K derived: sum of 2 quarters · filed 2026-08-12 | $1.20M 10-Q · filed 2025-11-13 | $1.60M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-12 | $900.00K 10-Q · filed 2026-08-12 | $1.30M derived: sum of 3 quarters · filed 2026-08-12 | $1.70M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-12 | $900.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.30M derived: sum of 3 quarters · filed 2026-05-12 | $1.70M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $800.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.20M derived: sum of 3 quarters · filed 2026-03-23 | $1.60M 10-K · filed 2026-03-23 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-13 | $800.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.20M 10-Q · filed 2025-11-13 | $1.60M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $800.00K 10-Q · filed 2025-08-14 | $1.20M derived: sum of 3 quarters · filed 2025-08-14 | $1.70M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-08 | $800.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.30M derived: sum of 3 quarters · filed 2025-05-08 | $1.70M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $900.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.30M derived: sum of 3 quarters · filed 2025-03-11 | $1.80M 10-K · filed 2025-03-11 |
| 2023-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $900.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.40M 10-Q · filed 2024-11-07 | $1.80M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $900.00K 10-Q · filed 2024-08-08 | $1.30M derived: sum of 3 quarters · filed 2024-08-08 | $1.80M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-14 | $900.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.40M derived: sum of 3 quarters · filed 2024-05-14 | $1.80M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $900.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.30M derived: sum of 3 quarters · filed 2024-04-01 | $1.70M 10-K · filed 2024-04-01 |
| 2022-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $900.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.30M 10-Q · filed 2023-11-09 | $1.70M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $800.00K 10-Q · filed 2023-08-14 | $1.20M derived: sum of 3 quarters · filed 2023-08-14 | $1.50M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-09 | $800.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.10M derived: sum of 3 quarters · filed 2023-05-09 | $1.40M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $700.00K derived: sum of 2 quarters · filed 2023-03-02 | $1.00M derived: sum of 3 quarters · filed 2023-03-02 | $1.40M 10-K · filed 2023-03-02 |
| 2021-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.00M 10-Q · filed 2022-11-09 | $1.40M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $700.00K 10-Q · filed 2022-08-09 | $1.10M derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-12 | $800.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.10M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $700.00K 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |